Daratumumab, Carfilzomib, Lenalidomide and Low Dose Dexamethasone (DKRd) in Newly Diagnosed, Multiple Myeloma
University of Chicago
University of Chicago
University of Pennsylvania
Cellectar Biosciences, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Pfizer
Weill Medical College of Cornell University
Oslo University Hospital
AbbVie
Icahn School of Medicine at Mount Sinai
University of Arkansas
City of Hope Medical Center
Arbeitsgemeinschaft medikamentoese Tumortherapie
US Oncology Research
International Myeloma Foundation